Ambient Fine Particulate Matter Exposures, Platelet Activation and Respiratory Morbidity in COPD: The SPIROMICS Air Study.

Home > Publications > Ambient Fine Particulate Matter Exposures, Platelet Activation and Respiratory Morbidity in COPD: The SPIROMICS Air Study.

A. Fawzy, N.N. Hansel, N. Putcha, A. Gassett, J.D. Kaufman, K. Koehler, L.M. Paulin, C.S. Pirozzi, M. Zusman, N.E. Alexis, I. Barjaktarevic, C. Bosma, M.K. Han, W.W. Labaki, F.J. Martinez, W.K. O'Neal, S.P. Peters, M.-L. Wilgus, P. Woodruff, R.G.G. Barr, C.L. Pistenmaa. Ambient Fine Particulate Matter Exposures, Platelet Activation and Respiratory Morbidity in COPD: The SPIROMICS Air Study. American Journal of Respiratory and Critical Care Medicine. 2025 May 1; 211(Abstracts):a4241-a4241.

2025
https://researcherprofiles.org/profile/618805213

A. Fawzy, N.N. Hansel, N. Putcha, A. Gassett, J.D. Kaufman, K. Koehler, L.M. Paulin, C.S. Pirozzi, M. Zusman, N.E. Alexis, I. Barjaktarevic, C. Bosma, M.K. Han, W.W. Labaki, F.J. Martinez, W.K. O'Neal, S.P. Peters, M.-L. Wilgus, P. Woodruff, R.G.G. Barr, C.L. Pistenmaa